05.18.23
Mary Kay and the European Society for Dermatological Research (ESDR) have awarded the inaugural Mary Kay-ESDR Skin Health/Skin Disease Research Grants to Dr. Clarisse Ganier and Dr. Michael Cangkrama. Each will receive $20,000 to further their contributions in skin disease research.
The grants, created in partnership with the European Society for Dermatological Research, were presented at a special virtual event prior to the First International Societies for Investigative Dermatology conference in May.
ESDR, founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. It is the largest investigative dermatology society in Europe with a current membership of about 1100.
“Mary Kay is dedicated to advancing skin and nutritional health research globally, and we know this cannot be done alone. Collaboration across industries, academic institutions, and clinicians is critical, which is why we are proud to partner with ESDR to furnish the first-ever Mary Kay-ESDR Skin Health/Skin Disease Research Grants,” said Dr. Lucy Gildea, chief innovation officer, product and science at Mary Kay. “These grants bring this larger community together for new inspiration for the future, and Mary Kay is proud to be a part of this opportunity. We are excited to see how these recipients bring greater advancements to different aspects of skin health research.”
Mary Kay said it received applications from scientists across all of Europe after the grant program was announced last year.
Dr. Ganier, a research associate at the Center of Gene Therapy and Regenerative Medicine in King’s College London, is part of the Human Cell Atlas initiative – an international collaborative effort to map all cell types within the human body – to generate a comprehensive Skin Cell Atlas. As part of this work, the team has created a multi-scale spatial atlas of healthy skin and basal cell carcinoma (BCC), incorporating single cell transcriptomics, in vivo optical coherence tomography, spatial global transcriptional profiling and in situ sequencing. Funding for this research will allow her to pursue her professional goals of starting her own laboratory focusing on skin cancer biology by combining multiomics data, both in vitro and ex vivo.
“On behalf of the ESDR board, we would like to thank Mary Kay for its support of the ESDR and congratulate this year’s grant recipients for their tremendous contributions to their respective fields. A key objective of our Society is to promote innovative research in investigative dermatology and to support researchers' activities in translational skin research,” said Eli Sprecher, Chair, Scientific Program Committee of ESDR.
The grants, created in partnership with the European Society for Dermatological Research, were presented at a special virtual event prior to the First International Societies for Investigative Dermatology conference in May.
ESDR, founded in 1970, is a non-profit organization promoting basic and clinical science related to dermatology. It is the largest investigative dermatology society in Europe with a current membership of about 1100.
“Mary Kay is dedicated to advancing skin and nutritional health research globally, and we know this cannot be done alone. Collaboration across industries, academic institutions, and clinicians is critical, which is why we are proud to partner with ESDR to furnish the first-ever Mary Kay-ESDR Skin Health/Skin Disease Research Grants,” said Dr. Lucy Gildea, chief innovation officer, product and science at Mary Kay. “These grants bring this larger community together for new inspiration for the future, and Mary Kay is proud to be a part of this opportunity. We are excited to see how these recipients bring greater advancements to different aspects of skin health research.”
Mary Kay said it received applications from scientists across all of Europe after the grant program was announced last year.
Grant Recipients
Dr. Cangkrama, a senior scientist, department of biology, Institute of Molecular Health Sciences, ETH Zürich, is working on molecular and cellular mechanisms underlying the development and progression of epithelial skin cancers, the most common types of cancer in humans. His research projects will focus on investigating molecular mechanisms of squamous cancer development and the role of the tumor microenvironment using state-of-the-art approaches. He will utilize the grant to further develop his independent projects and continue to pursue positions as an independent group leader or Assistant Professor in Europe.Dr. Ganier, a research associate at the Center of Gene Therapy and Regenerative Medicine in King’s College London, is part of the Human Cell Atlas initiative – an international collaborative effort to map all cell types within the human body – to generate a comprehensive Skin Cell Atlas. As part of this work, the team has created a multi-scale spatial atlas of healthy skin and basal cell carcinoma (BCC), incorporating single cell transcriptomics, in vivo optical coherence tomography, spatial global transcriptional profiling and in situ sequencing. Funding for this research will allow her to pursue her professional goals of starting her own laboratory focusing on skin cancer biology by combining multiomics data, both in vitro and ex vivo.
“On behalf of the ESDR board, we would like to thank Mary Kay for its support of the ESDR and congratulate this year’s grant recipients for their tremendous contributions to their respective fields. A key objective of our Society is to promote innovative research in investigative dermatology and to support researchers' activities in translational skin research,” said Eli Sprecher, Chair, Scientific Program Committee of ESDR.
